Skip to content

South San Francisco, CA, May 9, 2022 – FlemingMartin is pleased to announce that Circle Pharma, a pre-clinical stage company discovering and developing macrocycle therapeutics, has hired Linda Bergstedt as Executive Director & Head of People.

Linda Bergstedt brings 25 years of experience across the People function to Circle. She has worked inside both large companies and small/midsize organizations encompassing the biotechnology, medical device, healthcare, consumer product, and electrical distribution industries over her career. Linda’s greatest passion lies in providing strategic guidance to her leadership teams, developing trusting relationships with key stakeholders, and serving as a player-coach with her colleagues.

Previously, as Director of HR and HR Business Partner at Denali Therapeutics, Linda held a broad scope of responsibility during a period of high growth. Her career has also spanned across Relypsa, Graybar Electric Company, and Mar Cor Purification. Linda earned her MA in Organizational Leadership from St. Catherine University and her BA in Communication Studies & Women’s Studies from Hamline University.

Circle Pharma Logo 2 Circle Pharma is a pre-clinical stage company discovering and developing macrocycle therapeutics. At the leading edge of innovation, Circle is focused on therapeutic targets which have proven to be challenging to address with conventional small molecules or biologics, but which are well suited for macrocycles. The company’s initial focus is on intracellular protein-protein interactions that are key drivers in oncology pathways.

 

 

Fleming Martin Color Logo Medium 72 Ppi FlemingMartin is a leading retained executive search firm with offices in Northern and Southern California. FlemingMartin partners with Boards and CEOs to build successful execution-focused management teams. The Firm’s principals are trusted advisors and business partners who enable companies to gain powerful, far-reaching, and lasting contributions from their executive-level human capital. flemingmartin.com